These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33752528)

  • 21. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia].
    Zheng MM; Yue LJ; Chen XW; Wen FQ; Li CG; Yang CL; Xie C; Ding H
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):201-6. PubMed ID: 23498762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
    Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):283-9. PubMed ID: 24908438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of MTHFR C677T Polymorphism on High-Dose Methotrexate-Related Toxicity in Patients With Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
    Chang X; Guo Y; Su L; Zhang Y; Hui W; Zhao H; Hu R; Sun W
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):91-96. PubMed ID: 33069634
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Sundbaum JK; Baecklund E; Eriksson N; Hallberg P; Kohnke H; Wadelius M
    Pharmacogenomics; 2020 Apr; 21(5):337-346. PubMed ID: 32024416
    [No Abstract]   [Full Text] [Related]  

  • 25. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
    Yousef AM; Farhad R; Alshamaseen D; Alsheikh A; Zawiah M; Kadi T
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):755-762. PubMed ID: 30684021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia.
    Salazar J; Altés A; del Río E; Estella J; Rives S; Tasso M; Navajas A; Molina J; Villa M; Vivanco JL; Torrent M; Baiget M; Badell I
    Pharmacogenomics J; 2012 Oct; 12(5):379-85. PubMed ID: 21747412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Digestive disease in the immunocompromised patient with acute lymphoblastic leukemia. Experience of the IVth Pediatric Clinic--Oncology Department of the Iaşi Sfânta Maria Children's Hospital].
    Moisă SM; Rusu A; Dumitraş S; Burlea M; Miron I
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):356-65. PubMed ID: 19295004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
    van Kooten Niekerk PB; Schmiegelow K; Schroeder H
    Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma.
    Avivi I; Zuckerman T; Krivoy N; Efrati E
    Leuk Lymphoma; 2014 Mar; 55(3):565-70. PubMed ID: 23829278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermediate dose of methotrexate toxicity in non-Hodgkin lymphoma.
    Uluoğlu C; Oğuz A; Timlioğlu O; Biberoğlu G; Hasanoğlu A
    Gen Pharmacol; 1999 Feb; 32(2):215-8. PubMed ID: 10188622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of GSTP1 and MTHFR Gene Polymorphism on Side Effects of HD-MTX in ALL Children].
    Li F; Yin DD; Zhou XL; Ma JM; Guo HM; Meng L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):723-728. PubMed ID: 28641625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.
    Suthandiram S; Gan GG; Zain SM; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
    Pharmacogenomics; 2014 Aug; 15(11):1479-94. PubMed ID: 25303299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of MTHFR and ABCB1 polymorphisms with MTX-induced mucositis in Chinese paediatric patients with acute lymphoblastic leukaemia, lymphoma or osteosarcoma-A retrospective cohort study.
    Gong Y; Luo L; Wang L; Chen J; Chen F; Ma Y; Xu Z; Sun Y; Luo L; Shi C; Li X
    J Clin Pharm Ther; 2021 Dec; 46(6):1557-1563. PubMed ID: 34346513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate.
    D'Angelo V; Ramaglia M; Iannotta A; Francese M; Pota E; Affinita MC; Pecoraro G; Indolfi C; Di Martino M; Di Pinto D; Buffardi S; Poggi V; Indolfi P; Casale F
    Leuk Lymphoma; 2013 Dec; 54(12):2639-44. PubMed ID: 23488607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.
    Lopez-Lopez E; Ballesteros J; Piñan MA; Sanchez de Toledo J; Garcia de Andoin N; Garcia-Miguel P; Navajas A; Garcia-Orad A
    Pharmacogenet Genomics; 2013 Feb; 23(2):53-61. PubMed ID: 23222202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
    Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
    Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic Leukemia.
    Zahra FT; Nahid NA; Islam MR; Al-Mamun MMA; Apu MNH; Nahar Z; Kabir AL; Biswas SK; Ahmed MU; Islam MS; Hasnat A
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e58-e65. PubMed ID: 31884153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
    Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
    Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLCO1B1 *15 allele is associated with methotrexate-induced nausea in pediatric patients with inflammatory bowel disease.
    Mehta RS; Taylor ZL; Martin LJ; Rosen MJ; Ramsey LB
    Clin Transl Sci; 2022 Jan; 15(1):63-69. PubMed ID: 34423897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J; Kralovánszky J; Adleff V; Pap E; Németh K; Komlósi V; Kovács G
    Anticancer Res; 2008; 28(5B):3051-4. PubMed ID: 19031955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.